613 related articles for article (PubMed ID: 23385969)
21. Low prepregnancy adiponectin concentrations are associated with a marked increase in risk for development of gestational diabetes mellitus.
Hedderson MM; Darbinian J; Havel PJ; Quesenberry CP; Sridhar S; Ehrlich S; Ferrara A
Diabetes Care; 2013 Dec; 36(12):3930-7. PubMed ID: 23990523
[TBL] [Abstract][Full Text] [Related]
22. Overweight and obese in gestational diabetes: the impact on pregnancy outcome.
Langer O; Yogev Y; Xenakis EM; Brustman L
Am J Obstet Gynecol; 2005 Jun; 192(6):1768-76. PubMed ID: 15970805
[TBL] [Abstract][Full Text] [Related]
23. Changes in visfatin levels after oral glucose tolerance test in women with gestational diabetes mellitus.
Zhaoxia L; Ying W; Danqing C
Diabetes Res Clin Pract; 2012 Jun; 96(3):e76-9. PubMed ID: 22446095
[TBL] [Abstract][Full Text] [Related]
24. Leptin, resistin and visfatin as useful predictors of gestational diabetes mellitus.
Bawah AT; Seini MM; Abaka-Yawason A; Alidu H; Nanga S
Lipids Health Dis; 2019 Dec; 18(1):221. PubMed ID: 31836012
[TBL] [Abstract][Full Text] [Related]
25. High plasma retinol binding protein-4 and low plasma adiponectin concentrations are associated with severity of glucose intolerance in women with previous gestational diabetes mellitus.
Choi SH; Kwak SH; Youn BS; Lim S; Park YJ; Lee H; Lee N; Cho YM; Lee HK; Kim YB; Park KS; Jang HC
J Clin Endocrinol Metab; 2008 Aug; 93(8):3142-8. PubMed ID: 18492757
[TBL] [Abstract][Full Text] [Related]
26. Elevated serum levels of visfatin in gestational diabetes: a comparative study across various degrees of glucose tolerance.
Lewandowski KC; Stojanovic N; Press M; Tuck SM; Szosland K; Bienkiewicz M; Vatish M; Lewinski A; Prelevic GM; Randeva HS
Diabetologia; 2007 May; 50(5):1033-7. PubMed ID: 17334748
[TBL] [Abstract][Full Text] [Related]
27. Central visfatin potentiates glucose-stimulated insulin secretion and β-cell mass without increasing serum visfatin levels in diabetic rats.
Kim DS; Kang S; Moon NR; Park S
Cytokine; 2014 Feb; 65(2):159-66. PubMed ID: 24332931
[TBL] [Abstract][Full Text] [Related]
28. Serum adipokines (adiponectin and resistin) correlation in developing gestational diabetes mellitus: pilot study.
Siddiqui K; George TP; Nawaz SS; Shehata N; El-Sayed AA; Khanam L
Gynecol Endocrinol; 2018 Jun; 34(6):502-506. PubMed ID: 29207892
[TBL] [Abstract][Full Text] [Related]
29. Heterogeneity of insulin resistance and beta cell dysfunction in gestational diabetes mellitus: a prospective cohort study of perinatal outcomes.
Liu Y; Hou W; Meng X; Zhao W; Pan J; Tang J; Huang Y; Tao M; Liu F
J Transl Med; 2018 Oct; 16(1):289. PubMed ID: 30355279
[TBL] [Abstract][Full Text] [Related]
30. Maternal pregravid weight is the primary determinant of serum leptin and its metabolic associations in pregnancy, irrespective of gestational glucose tolerance status.
Maple-Brown L; Ye C; Hanley AJ; Connelly PW; Sermer M; Zinman B; Retnakaran R
J Clin Endocrinol Metab; 2012 Nov; 97(11):4148-55. PubMed ID: 22948759
[TBL] [Abstract][Full Text] [Related]
31. [Effects of dietary fat on onset of gestational diabetes mellitus].
Ying H; Wang DF
Zhonghua Fu Chan Ke Za Zhi; 2006 Nov; 41(11):729-31. PubMed ID: 17327027
[TBL] [Abstract][Full Text] [Related]
32. Plasma visfatin levels in pregnant women with normal glucose tolerance, gestational diabetes and pre-gestational diabetes mellitus.
Coskun A; Ozkaya M; Kiran G; Kilinc M; Arikan DC
J Matern Fetal Neonatal Med; 2010 Sep; 23(9):1014-8. PubMed ID: 20059442
[TBL] [Abstract][Full Text] [Related]
33. Serum levels of visfatin and possible interaction with iron parameters in gestational diabetes mellitus.
Kaygusuz I; Gumus II; Yılmaz S; Simavlı S; Uysal S; Derbent AU; Gözdemir E; Kafalı H
Gynecol Obstet Invest; 2013; 75(3):203-9. PubMed ID: 23548246
[TBL] [Abstract][Full Text] [Related]
34. Maternal serum visfatin at 11-13 weeks of gestation in gestational diabetes mellitus.
Ferreira AF; Rezende JC; Vaikousi E; Akolekar R; Nicolaides KH
Clin Chem; 2011 Apr; 57(4):609-13. PubMed ID: 21325104
[TBL] [Abstract][Full Text] [Related]
35. Maternal plasma adiponectin concentrations at 24 to 31 weeks of gestation: negative association with gestational diabetes mellitus.
Tsai PJ; Yu CH; Hsu SP; Lee YH; Huang IT; Ho SC; Chu CH
Nutrition; 2005; 21(11-12):1095-9. PubMed ID: 16308131
[TBL] [Abstract][Full Text] [Related]
36. Association between circulating visfatin and gestational diabetes mellitus: a systematic review and meta-analysis.
Zhang W; Zhao D; Meng Z; Wang H; Zhao K; Feng X; Li Y; Dun A; Jin X; Hou H
Acta Diabetol; 2018 Nov; 55(11):1113-1120. PubMed ID: 29992461
[TBL] [Abstract][Full Text] [Related]
37. Nutrient intake of women with and without gestational diabetes with a specific focus on fatty acids.
Thomas B; Ghebremeskel K; Lowy C; Crawford M; Offley-Shore B
Nutrition; 2006 Mar; 22(3):230-6. PubMed ID: 16500549
[TBL] [Abstract][Full Text] [Related]
38. Are third-trimester adipokines associated with higher metabolic risk among women with gestational diabetes?
Honnorat D; Disse E; Millot L; Mathiotte E; Claret M; Charrie A; Drai J; Garnier L; Maurice C; Durand E; Simon C; Dupuis O; Thivolet C
Diabetes Metab; 2015 Nov; 41(5):393-400. PubMed ID: 25890778
[TBL] [Abstract][Full Text] [Related]
39. Adipokine levels and their association with insulin resistance and fetal outcomes among the newborns of Indian gestational diabetic mothers.
Manoharan B; Bobby Z; Dorairajan G; Vinayagam V; Packirisamy RM
Saudi Med J; 2019 Apr; 40(4):353-359. PubMed ID: 30957128
[TBL] [Abstract][Full Text] [Related]
40. The Impact of Prepregnancy Body Mass Index and Gestational Weight Gain on Perinatal Outcomes for Women With Gestational Diabetes Mellitus.
Chiou YL; Hung CH; Liao HY
Worldviews Evid Based Nurs; 2018 Aug; 15(4):313-322. PubMed ID: 29962105
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
